Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Cathay International Holdings Ltd (CTI) Common Shares USD0.01

Sell:0.80p Buy:1.50p 0 Change: No change
Market closed Prices as at close on 3 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.80p
Buy:1.50p
Change: No change
Market closed Prices as at close on 3 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.80p
Buy:1.50p
Change: No change
Market closed Prices as at close on 3 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

CATHAY INTERNATIONAL HOLDINGS LIMITED is an investment holding company principally engaged in the healthcare business. The Company operates five business segments through its subsidiaries. The Lansen segment engages in the manufacture and sale of pharmaceuticals, cosmeceutical products and plant extracts and healthcare products. The Haizi segment produces inositol and its by-product, di-calcium phosphate. The Natural Dailyhealth segment is involved in the production and sales of plant extracts for use as active ingredients in health products. The Botai segment involves in the production and sales of collagen injectable fillers and development of collagen related products. The Hotel Operation segment operates a hotel.

Contact details

Address:
Suites 1203-4, 12/F, Li Po Chun Chambers
189 Des Voeux Road Central
Hong Kong

Hong Kong
Telephone:
+852 (0) 28289289
Website:
www.cathay-intl.com.hk

Important dates

Future events
There are no future events available.
Past events
Annual report 21 April 2020 21/04/20
Final results 01 April 2020 01/04/20
Annual report 01 April 2020 01/04/20
Trading Announcement 11 February 2020 11/02/20
Interim results 30 August 2019 30/08/19
Trading Announcement 25 July 2019 25/07/19

General stock information

EPIC:
CTI
ISIN:
BMG1965E1030
Market cap:
£22.11 million
Shares in issue:
1.92 billion
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Ka Chi Siu
    Finance Director, Executive Director
  • Patrick Sung
    Controller, Executive Director
  • Chi Hung Yiu
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.